Cyrano Therapeutics

Get Full Access


  • The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being. Currently no marketed therapy exists and aside from the Cyrano product, none are in the pipeline. Cyrano has established the IP estate with the assistance of Wilson Sonsini. Key patents have been issued. The Cyrano product (CYR-001) repurposes an approved molecule (Theophylline) for this new indication and has been tested with success in a pilot study. Eight out of the 10 patients treated had significant improvement in taste and smell within 2 weeks with no reported side effects. The primary treatment provider will be the Otolaryngologist (Ear, Nose, and Throat specialist) and credible clinical investigators in this specialty have been identified and have expressed interest in participating in the clinical program. Currently we are seeking a partner to fund up to $5M to fund a Phase 2A study to determine an optimal dose and validate the therapy in a double-blind randomized setting. A Pre-IND meeting with FDA has been held and their positive feedback has been incorporated into the plan. Given the 505(b)(2) regulatory pathway, the company expects the pathway to market to be accelerated.
  • location

    Headquarters:5125 Macarthur Boulevard , Washington, District Of Columbia, United States

  • Cyrano Therapeutics phone

    Phone Number:

  • Cyrano Therapeutics website


  • Cyrano Therapeutics employees


  • Cyrano Therapeutics revenue

    Revenue:$0 - 1M

  • Cyrano Therapeutics legal name

    Legal Name:Cyrano Therapeutics

  • Cyrano Therapeutics's Social Media

    Cyrano Therapeutics linkedin
  • done Is this data correct?
  • |  NAICS Code: 332994  |

    Show More
Person level website identification

CEO for Cyrano Therapeutics

Rick Geoffrion

President And Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Jerry Andry

Vice President Clinical And Regulatory Affairs

Frequently Asked Questions regarding Cyrano Therapeutics

  • Where are Cyrano Therapeutics's Headquarters?

    Cyrano Therapeutics's Headquarters are in 5125 Macarthur Boulevard ,Washington,District Of Columbia,United States

  • What is Cyrano Therapeutics's official website?

    Cyrano Therapeutics's official website is

  • What is Cyrano Therapeutics's Revenue?

    Cyrano Therapeutics's revenue is $0 - 1M

  • What is Cyrano Therapeutics's NAICS code?

    Cyrano Therapeutics's NAICS code is 332994

  • How many employees are working in Cyrano Therapeutics

    Cyrano Therapeutics has 2 employees

  • What is Cyrano Therapeutics's Industry?

    Cyrano Therapeutics is in the industry of Medical Devices

  • Who is Cyrano Therapeutics's CEO?

    Cyrano Therapeutics's CEO is Rick Geoffrion

  • Who is Cyrano Therapeutics's Vice President Clinical And Regulatory Affairs?

    Cyrano Therapeutics's Vice President Clinical And Regulatory Affairs is Jerry Andry

Company Directory